Polymorphisms of the Thiazide's Receptor Gene SLC12A3 and Development of Hyponatremia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01346891|
Recruitment Status : Completed
First Posted : May 3, 2011
Last Update Posted : July 6, 2011
|Condition or disease|
|Thiazide Diuretics Induced Hyponatremia|
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Observational Model:||Case Control|
|Official Title:||Polymorphisms of the Thiazide's Receptor Gene SLC12A3 and Development of Hyponatremia|
|Study Start Date :||July 2010|
Hyponatremia Group (Cases)
Patients over 21 years old, with confirmed antecedent of thiazide-induced hyponatremia who required hospitalization with a serum sodium concentration lower than 125 meq/L.
Good Thiazide Tolerance (Controls)
Patients over 21 years old, who have consumed thiazide diuretics for more than 2 years, with a serum sodium concentration persistently over 135 meq/L.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01346891
|Hospital Italiano de Buenos Aires|
|Capital Federal, Argentina, C1181ACH|
|Principal Investigator:||Diego H Giunta, MD||Hospital Italiano de Buenos Aires|